Form 8-K - Current report:
SEC Accession No. 0001656472-24-000101
Filing Date
2024-11-12
Accepted
2024-11-12 07:32:14
Documents
15
Period of Report
2024-11-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K cron-20241112.htm   iXBRL 8-K 28288
2 EX-99.1 pressreleaseq32024qformat.htm EX-99.1 723629
6 image_0a.jpg GRAPHIC 10212
  Complete submission text file 0001656472-24-000101.txt   930007

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cron-20241112.xsd EX-101.SCH 1804
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cron-20241112_lab.xml EX-101.LAB 20678
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cron-20241112_pre.xml EX-101.PRE 12394
18 EXTRACTED XBRL INSTANCE DOCUMENT cron-20241112_htm.xml XML 2587
Mailing Address 6D - 7398 YONGE ST PMB 732 THORNHILL A6 L4J 8J2
Business Address 4491 CONCESSION RD 12 STAYNER A6 L0M 1S0 (416) 504-0004
Cronos Group Inc. (Filer) CIK: 0001656472 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38403 | Film No.: 241443321
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)